Feasibility of F-18 FDG PET/CT Scan for Abdomino-Pelvic Regions -The 3<sup>rd</sup> Chapter-

DOI Web Site Web Site Web Site 1 Citations 207 References Open Access
  • SUGA Kazuyoshi
    Site of Semui PET Cancer Screening and Radiation Therapy, St. Hill Hospital

Bibliographic Information

Other Title
  • 腹部・骨盤部領域におけるF-18 FDG PET/CT検査の意義－パート３－
  • フクブ コツバンブ リョウイキ ニオケル F-18 FDG PET CT ケンサ ノ イギ : パート 3

Search this article

Abstract

Positron emission tomography (PET) or PET/CT with 2-[fluorine 18] fluoro-2-deoxy-d-glucose (FDG) plays an important role for diagnosis and management in patients with various malignancies, as the recent meta-analysis has shown significant changes of management in approximately one-third patients with various malignancies with additional use of FDG PET scan. In gynecological region, the National Comprehensive Cancer Network Overian/Uterine Cancer Guideline recommends the use of FDG PET in detecting recurrent lesions with negative CT/MR imaging findings and rising tumor marker levels and in obtaining confirmative diagnosis of CT/MR-indeterminate lesions. In urogenital region, the evidences indicating of the utility of FDG PET for initial staging and re-staging after surgery are now being accumulated, regardless of some inherent limitations in evaluation primary lesions. At this final chapter for the review of the feasibility of FDG PET/CT in abdomino-pelvic regions, the content is focused on the utility and limitations of this technique in gynecological/urogenital oncology.

Journal

Citations (1)*help

See more

References(207)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top